Overview

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

Status:
RECRUITING
Trial end date:
2028-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test different doses of abemaciclib to find the best dose in participants while receiving hormone therapy and radiation therapy.
Phase:
PHASE1
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborator:
Eli Lilly and Company
Treatments:
abemaciclib
Radiotherapy